Table of Contents
Table 5-9: Cass
Table 5-11: Clay
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 270 | 616.3 | 1,328 | 632.4 | 119 | 285.9 | 597 | 298.1 |
| Esophagus | * | # | 9 | 4.1** | * | # | 10 | 5.0** |
| Stomach | 6 | 15.6** | 27 | 12.9 | * | # | 12 | 5.8** |
| Colon excluding Rectum | 15 | 34.6** | 97 | 48.3 | 13 | 31.7** | 61 | 31.1 |
| Rectum and Rectosigmoid Junction | 5 | 11.7** | 39 | 19.0 | * | # | 9 | 4.5** |
| Liver | * | # | 9 | 3.8** | * | # | 5 | 2.5** |
| Pancreas | 8 | 17.4** | 25 | 11.7 | 7 | 16.1** | 23 | 11.3 |
| Lung and Bronchus | 54 | 124.3 | 275 | 133.6 | 43 | 97.6 | 242 | 119.3 |
| Melanoma of the Skin | 12 | 28.2** | 39 | 18.4 | * | # | 6 | 2.4** |
| Prostate | 77 | 172.6 | 380 | 182.7 | 12 | 35.3** | 50 | 28.0 |
| Urinary Bladder | 18 | 41.2** | 94 | 45.0 | * | # | 20 | 11.2 |
| Kidney and Renal Pelvis | 12 | 27.0** | 51 | 23.1 | * | # | 16 | 7.4** |
| Brain and Other Nervous System | 6 | 11.7** | 28 | 12.5 | 5 | 10.1** | 21 | 9.6 |
| Non-Hodgkin Lymphoma | 9 | 22.5** | 41 | 19.3 | 7 | 17.7** | 21 | 10.5 |
| Myeloma | * | # | 13 | 6.5** | * | # | 11 | 6.0** |
| Leukemia | 5 | 11.3** | 26 | 12.7 | * | # | 16 | 7.9** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 265 | 458.1 | 1,250 | 449.7 | 126 | 213.9 | 561 | 198.1 |
| Colon excluding Rectum | 32 | 54.5 | 121 | 42.4 | 5 | 8.3** | 47 | 16.3 |
| Rectum and Rectosigmoid Junction | 9 | 15.1** | 38 | 13.3 | * | # | 7 | 2.4** |
| Liver | * | # | 8 | 2.8** | * | # | 7 | 2.5** |
| Pancreas | 6 | 10.3** | 24 | 8.5 | 9 | 15.0** | 22 | 7.9 |
| Lung and Bronchus | 46 | 78.0 | 217 | 76.9 | 40 | 68.0 | 179 | 63.3 |
| Melanoma of the Skin | 8 | 15.0** | 35 | 12.9 | * | # | 6 | 2.0** |
| Breast | 68 | 117.8 | 375 | 135.6 | 11 | 19.4** | 82 | 29.1 |
| Cervix Uteri | * | # | 34 | 12.8 | 5 | 8.1** | 12 | 4.3** |
| Corpus Uteri | 11 | 18.7** | 53 | 18.8 | * | # | 5 | 1.8** |
| Ovary | 13 | 22.4** | 53 | 19.4 | 12 | 20.2** | 34 | 12.0 |
| Urinary Bladder | * | # | 27 | 9.7 | * | # | 1 | # |
| Kidney and Renal Pelvis | 14 | 23.6** | 30 | 10.8 | 6 | 9.8** | 9 | 3.2** |
| Brain and Other Nervous System | * | # | 12 | 4.5** | 6 | 10.5** | 11 | 4.0** |
| Non-Hodgkin Lymphoma | 16 | 29.0** | 44 | 16.2 | * | # | 17 | 5.9** |
| Myeloma | * | # | 11 | 3.9** | * | # | 10 | 3.6** |
| Leukemia | 9 | 16.0** | 32 | 11.8 | * | # | 29 | 10.3 |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, July 2006
Table of Contents
Table 5-9: Cass
Table 5-11: Clay
